Experienced in Sensorimotor Polyneuropathy

Dr. Leigh K. Ramos-Platt

Pediatric Neurology | Pediatrics | Neurology
4650 W Sunset Blvd, Ms #82, 
Los Angeles, CA 
Experienced in Sensorimotor Polyneuropathy
4650 W Sunset Blvd, Ms #82, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Leigh Ramos-Platt is a Pediatric Neurologist and a Pediatrics provider in Los Angeles, California. Dr. Ramos-Platt is rated as an Experienced provider by MediFind in the treatment of Sensorimotor Polyneuropathy. Her top areas of expertise are Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Acute Flaccid Myelitis (AFM), and Generalized Tonic-Clonic Seizure.

Her clinical research consists of co-authoring 20 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Neurology
Pediatrics
Neurology
Licenses
Pediatrics in CA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HMSA
  • HMO
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 5 Less Insurance Carriers -

Locations

4650 W Sunset Blvd, Ms #82, Los Angeles, CA 90027

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy
Enrollment Status: Active_not_recruiting
Publish Date: September 23, 2025
Intervention Type: Drug
Study Drugs: SRP-4045 Exon 45-Skipping Treatment, SRP-4053 Exon 53-Skipping Treatment
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: August 26, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
A Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Ataluren in Patients With Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension
Enrollment Status: Completed
Publish Date: January 18, 2024
Intervention Type: Drug
Study Drug: Ataluren
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients With Duchenne Muscular Dystrophy
Enrollment Status: Completed
Publish Date: June 21, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
A Phase III Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Who Completed the SIDEROS Study
Enrollment Status: Terminated
Publish Date: December 03, 2021
Intervention Type: Drug
Study Drug: Idebenone
Study Phase: Phase 3
View 4 Less Clinical Trials

18 Total Publications

Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder.
Safety and tolerability of intravenous immunoglobulin infusion in Down syndrome regression disorder.
Journal: American journal of medical genetics. Part A
Published: October 16, 2023
Similar Doctors
Distinguished in Sensorimotor Polyneuropathy
Dr. Mohsen I. Ali
Neurology
Distinguished in Sensorimotor Polyneuropathy
Dr. Mohsen I. Ali
Neurology
1330 W Covina Blvd, Suite 103, 
San Dimas, CA 
 (26.1 miles away)
909-592-2145
Languages Spoken:
English
See accepted insurances

Mohsen Ali is a Neurologist in San Dimas, California. Dr. Ali is rated as a Distinguished provider by MediFind in the treatment of Sensorimotor Polyneuropathy. His top areas of expertise are Generalized Tonic-Clonic Seizure, Seizures, Tension Headache, and Memory Loss.

Advanced in Sensorimotor Polyneuropathy
Dr. Richard A. Lewis
Neurology
Advanced in Sensorimotor Polyneuropathy
Dr. Richard A. Lewis
Neurology

Cedars-Sinai Medical Center

8700 Beverly Blvd, 
West Hollywood, CA 
 (5.4 miles away)
310-423-3277
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Lewis is a Neurologist in West Hollywood, California. Dr. Lewis is rated as a Distinguished provider by MediFind in the treatment of Sensorimotor Polyneuropathy. His top areas of expertise are Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy (SMA), and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Lewis is currently accepting new patients.

Advanced in Sensorimotor Polyneuropathy
Dr. Said R. Beydoun
Neurology
Advanced in Sensorimotor Polyneuropathy
Dr. Said R. Beydoun
Neurology

USC Care Medical Group Inc

1520 San Pablo St, Fl 4, 
Los Angeles, CA 
 (5.5 miles away)
800-872-2273
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Said Beydoun is a Neurologist in Los Angeles, California. Dr. Beydoun is rated as a Distinguished provider by MediFind in the treatment of Sensorimotor Polyneuropathy. His top areas of expertise are Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spinal and Bulbar Muscular Atrophy, and Thymectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ramos-Platt's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile